Article Image

App of the Week: DoseMeRx

Op-Med is a collection of original articles contributed by Doximity members.

Disclaimer: Doximity is not an affiliate of DoseMeRx and does not receive any compensation for this review.

Summary of app features: DoseMeRx is a clinical tool that uses researched drug models and patient information to determine individualized dosing information for patients. With a subscription, the software runs on an app interface where clinicians can enter patient information and get dosing recommendations. In addition, the information produced by DoseMeRx can be integrated with EHR systems.

This app is useful for: any physician prescribing medication, especially pediatricians, oncologists, and internists.

Good User Review: Currently, there are no user reviews on app platforms, but DoseMeRx provides some evidence for their software on their website.

Limitations: Currently, the dosing tool only works for some classes of drug but the platform will continue to expand over time.

Alternatives: This is a unique and personalized dosing software, but typical drug references are potential alternatives. There are many of these available including and Epocrates Medical References.

Download: After purchasing a subscription through their website, you can download DoseMeRx for free on the App Store or on Google Play.

Do you use this app? Let us know what you think about it in the comments!

Be featured: Are you a medical professional who has created a health app? Or do you know of an app that we should review? Let us know about it here.

Stay on top of the latest medical news, keep in touch with colleagues, send and receive HIPAA-secure faxes, and call your patients without *67 – all on the FREE Doximity app. Click here to download!

Illustration by Yi-Min Chun

All opinions published on Op-Med are the author’s and do not reflect the official position of Doximity or its editors. Op-Med is a safe space for free expression and diverse perspectives. For more information, or to submit your own opinion, please see our submission guidelines or email

More from Op-Med